Exosome-based therapy and targeted PROTAC delivery: A new nanomedicine frontier for HPV-mediated cervical cancer treatment
Nobendu Mukerjee, Swastika Maitra, Arabinda Ghosh
Exosome-based therapy and targeted PROTAC delivery: A new nanomedicine frontier for HPV-mediated cervical cancer treatment
[1] |
Khan I, Harshithkumar R, More A, Mukherjee A. Human papilloma virus: an unraveled enigma of universal burden of malignancies. Pathogens. 2023;12(4):564.
|
[2] |
Yim EK, Park JS. The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer Res Treat. 2005;37(6):319-324.
|
[3] |
Burmeister CA, Khan SF, Schäfer G, et al. Cervical cancer therapies: current challenges and future perspectives. Tumour Virus Res. 2022;13:200238.
|
[4] |
Maitra S, Mukerjee N, Alharbi HM, Ghosh A, Alexiou A, Thorat ND. Targeted therapies for HPV-associated cervical cancer: harnessing the potential of exosome-based chipsets in combating leukemia and HPV-mediated cervical cancer. J Med Virol. 2024;96(4):e29596.
|
[5] |
Wang C, Zhang Y, Chen W, et al. New-generation advanced PROTACs as potential therapeutic agents in cancer therapy. Mol Cancer. 2024;23:110.
|
[6] |
Mukerjee N, Maitra S, Ghosh A, Subramaniyan V, Sharma R. Exosome-mediated PROTACs delivery to target viral infections. Drug Dev Res. 2023;84(6):1031-1036.
|
[7] |
Koh HB, Kim HJ, Kang SW, Yoo TH. Exosome-based drug delivery: translation from bench to clinic. Pharmaceutics. 2023;15(8):2042.
|
[8] |
Aqil F, Gupta RC. Exosomes in cancer therapy. Cancers (Basel). 2022;14(3):500.
|
[9] |
Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019;8(7):727.
|
[10] |
Lee YJ, Shin KJ, Chae YC. Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer. Exp Mol Med. 2024;56:877-889.
|
[11] |
Danishuddin
CrossRef
Google scholar
|
/
〈 | 〉 |